Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial

Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial

<p>Background: In sub-Saharan Africa, 20%-25% of people starting ART have severe immunosuppression; ~10% die within three months. In the recently-reported REALITY randomized trial, a broad enhanced anti-infection prophylaxis bundle reduced all-cause mortality versus cotrimoxazole alone; here,...

Full description

Bibliographic Details
Main Authors: Post, F, Szubert, A, Prendergast, A, Johnston, V, Lyall, H, Fitzgerald, F, Musiime, V, Musoro, G, Chepkrorir, P, Agutu, C, Mallewa, J, Rajapakse, C, Wilkes, H, Hakim, J, Mugyenyi, P, Walker, A, Gibb, D, Pett, S, on behalf of the REALITY trial team
Format: Journal article
Published: Oxford University Press 2018

Similar Items

Similar Items